| Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade P Charoentong, F Finotello, M Angelova, C Mayer, M Efremova, D Rieder, ... Cell reports 18 (1), 248-262, 2017 | 2417 | 2017 |
| International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ... The Lancet 391 (10135), 2128-2139, 2018 | 1532 | 2018 |
| Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability B Mlecnik, G Bindea, HK Angell, P Maby, M Angelova, D Tougeron, ... Immunity 44 (3), 698-711, 2016 | 898 | 2016 |
| Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy M Angelova, P Charoentong, H Hackl, ML Fischer, R Snajder, ... Genome biology 16, 1-17, 2015 | 458 | 2015 |
| The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis B Mlecnik, G Bindea, A Kirilovsky, HK Angell, AC Obenauf, M Tosolini, ... Science translational medicine 8 (327), 327ra26-327ra26, 2016 | 414 | 2016 |
| Evolution of metastases in space and time under immune selection M Angelova, B Mlecnik, A Vasaturo, G Bindea, T Fredriksen, L Lafontaine, ... Cell 175 (3), 751-765. e16, 2018 | 329 | 2018 |
| The link between the multiverse of immune microenvironments in metastases and the survival of colorectal cancer patients M Van den Eynde, B Mlecnik, G Bindea, T Fredriksen, SE Church, ... Cancer cell 34 (6), 1012-1026. e3, 2018 | 211 | 2018 |
| Immune evasion before tumour invasion in early lung squamous carcinogenesis C Mascaux, M Angelova, A Vasaturo, J Beane, K Hijazi, G Anthoine, ... Nature 571 (7766), 570-575, 2019 | 208 | 2019 |
| The coordinated action of the MVB pathway and autophagy ensures cell survival during starvation M Müller, O Schmidt, M Angelova, K Faserl, S Weys, L Kremser, ... Elife 4, e07736, 2015 | 109 | 2015 |
| miR-22 and miR-29a are members of the androgen receptor cistrome modulating LAMC1 and Mcl-1 in prostate cancer L Pasqualini, H Bu, M Puhr, N Narisu, J Rainer, B Schlick, G Schäfer, ... Molecular endocrinology 29 (7), 1037-1054, 2015 | 76 | 2015 |
| Endosome and Golgi‐associated degradation (EGAD) of membrane proteins regulates sphingolipid metabolism O Schmidt, Y Weyer, V Baumann, MA Widerin, S Eising, M Angelova, ... The EMBO Journal 38 (15), e101433, 2019 | 63 | 2019 |
| Bioinformatics for cancer immunology and immunotherapy P Charoentong, M Angelova, M Efremova, R Gallasch, H Hackl, J Galon, ... Cancer Immunology, Immunotherapy 61, 1885-1903, 2012 | 58 | 2012 |
| Induction of APOBEC3 exacerbates DNA replication stress and chromosomal instability in early breast and lung cancer evolution S Venkatesan, M Angelova, C Puttick, H Zhai, DR Caswell, WT Lu, ... Cancer discovery 11 (10), 2456-2473, 2021 | 48 | 2021 |
| Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry F Van Maldegem, K Valand, M Cole, H Patel, M Angelova, S Rana, ... Nature Communications 12 (1), 5906, 2021 | 28 | 2021 |
| Computational methods for gene finding in prokaryotes M Angelova, S Kalajdziski, L Kocarev ICT Innovations 2010 Web Proceedings, 2010 | 21 | 2010 |
| A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer Y Wu, D Biswas, I Usaite, M Angelova, S Boeing, T Karasaki, S Veeriah, ... Nature cancer 3 (6), 696-709, 2022 | 15 | 2022 |
| The colorectal cancer immune paradox revisited M Angelova, P Charoentong, H Hackl, Z Trajanoski Oncoimmunology 5 (2), e1078058, 2016 | 12 | 2016 |
| TOR complex 2 (TORC2) signaling and the ESCRT machinery cooperate in the protection of plasma membrane integrity in yeast O Schmidt, Y Weyer, S Sprenger, MA Widerin, S Eising, V Baumann, ... Journal of Biological Chemistry 295 (34), 12028-12044, 2020 | 10 | 2020 |
| The evolution of lung cancer and impact of subclonal selection in TRACERx AM Frankell, M Dietzen, M Al Bakir, EL Lim, T Karasaki, S Ward, ... Nature, 1-9, 2023 | 8 | 2023 |
| 31st annual meeting and associated programs of the Society for Immunotherapy of cancer (SITC 2016): late breaking abstracts S Althammer, K Steele, M Rebelatto, TH Tan, T Wiestler, G Schmidt, ... Journal for ImmunoTherapy of Cancer 4 (2), 223-242, 2016 | 7 | 2016 |
